Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
![]() |
![]() ![]() |
Ultima descărcare din IBN: 2023-12-02 10:31 |
Căutarea după subiecte similare conform CZU |
577.1+575+614.2 (3) |
Material bases of life. Biochemistry. Molecular biology. Biophysics (669) |
General genetics. General cytogenetics (430) |
Public and professional organization of health (880) |
![]() CIOBANU, Eugeniu. Personalised medicine in the bioethical context of contemporary society. In: Revista de Ştiinţe ale Sănătăţii din Moldova, 2022, nr. 3 An.1(29), p. 162. ISSN 2345-1467. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Revista de Ştiinţe ale Sănătăţii din Moldova | ||||||
Numărul 3 An.1(29) / 2022 / ISSN 2345-1467 | ||||||
|
||||||
CZU: 577.1+575+614.2 | ||||||
Pag. 162-162 | ||||||
|
||||||
![]() |
||||||
Rezumat | ||||||
Introduction. Over the last 10 years, as the technology and knowledge base of personalized medicine has developed, bioethicists have begun to think about the ethical and social implications for this approach, forming the field of inquiry known as ‘ELSI’. Objective of the study. To observe and elucidate the driving forces behind the evolution and direction of personalized medicine and the possible ethical issues that may result. Material and Methods. For the study, a thorough analysis of bibliographical sources focused both on the bioethical and moral aspects of the topic under study, as well as on the scientific and legal aspects, was carried out. Results. There is a need to broaden the scope of work on the ethical, legal, and social challenges raised by personalized medicine to take into account its increasing clinical applications throughout the health system. The fields of bioethics and clinical ethics have a rich tradition of addressing issues such as health disparities, patient confidentiality and the doctor-patient relationship. Conclusion. Although personalized medicine is becoming more feasible due to advances in technology - mainly ethics shaping the development of such a science. At the same time, ensuring that previously established moral and ethical barriers to scientific research are respected. |
||||||
Cuvinte-cheie Personalized Medicine, genetic testing, availability, ethical barriers, medicina personalizată, teste genetice, Disponibilitate, bariere etice |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-168539</cfResPublId> <cfResPublDate>2022-10-21</cfResPublDate> <cfVol>29</cfVol> <cfIssue>3 An.1</cfIssue> <cfStartPage>162</cfStartPage> <cfISSN>2345-1467</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/168539</cfURI> <cfTitle cfLangCode='EN' cfTrans='o'>Personalised medicine in the bioethical context of contemporary society</cfTitle> <cfKeyw cfLangCode='EN' cfTrans='o'>Personalized Medicine; genetic testing; availability; ethical barriers; medicina personalizată; teste genetice; Disponibilitate; bariere etice</cfKeyw> <cfAbstr cfLangCode='EN' cfTrans='o'><p>Introduction. Over the last 10 years, as the technology and knowledge base of personalized medicine has developed, bioethicists have begun to think about the ethical and social implications for this approach, forming the field of inquiry known as ‘ELSI’. Objective of the study. To observe and elucidate the driving forces behind the evolution and direction of personalized medicine and the possible ethical issues that may result. Material and Methods. For the study, a thorough analysis of bibliographical sources focused both on the bioethical and moral aspects of the topic under study, as well as on the scientific and legal aspects, was carried out. Results. There is a need to broaden the scope of work on the ethical, legal, and social challenges raised by personalized medicine to take into account its increasing clinical applications throughout the health system. The fields of bioethics and clinical ethics have a rich tradition of addressing issues such as health disparities, patient confidentiality and the doctor-patient relationship. Conclusion. Although personalized medicine is becoming more feasible due to advances in technology - mainly ethics shaping the development of such a science. At the same time, ensuring that previously established moral and ethical barriers to scientific research are respected.</p></cfAbstr> <cfAbstr cfLangCode='RO' cfTrans='o'><p>Introducere. În ultimii 10 ani, pe măsură ce tehnologia și baza de cunoștințe ale medicinei personalizate s-au dezvoltat, cercetătorii în bioetică au început să se gândească la implicațiile etice și sociale pentru această abordare, formând domeniul de investigație cunoscut sub numele „ELSI”. Scopul lucrării. Observarea și elucidarea forțelor motrice ce stau la baza evoluției și direcționării medicinei personalizate precum și posibilele probleme etice ce pot rezulta. Material și Metode. Pentru realizarea studiului au fost supuse unei analize minuțioase surse bibliografice axate atât pe aspectele bioetice și morale ale temei studiate, precum și pe cele științifice și juridice. Rezultate. Se observă necesitatea extinderii domeniului de aplicare a lucrărilor privind provocările etice, juridice și sociale ridicate de medicina personalizată pentru a ține cont de aplicațiile clinice din ce în ce mai numeroase ale acesteia în întregul sistem de sănătate. Domeniile bioeticii și eticii clinice au o tradiție bogată în abordarea unor aspecte precum disparitățile în materie de sănătate, confidențialitatea pacienților și relația medic-pacient. Concluzie. Deși medicina personalizată devine mai realizabilă datorită avansului tehnologiei – în mod principal etice care modelează dezvoltarea unei astfel de științe. În același timp asigurând respectarea barierelor morale și etice anterior stabilite în vederea cercetărilor științifice.</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2022-10-21T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2022-10-21T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-42612</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2022-10-21T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-42612</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-42612-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2022-10-21T24:00:00</cfStartDate> <cfFamilyNames>Ciobanu</cfFamilyNames> <cfFirstNames>Eugeniu</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>